Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
04-Apr-15 Jakarta residents have welcomed warmly the city-wide inauguration of 15 type D hospitals, which can provide more advanced healthcare than they could when their status was community health centers (Puskesmas) at district level. [image: Jakarta Post]
Read More
04-Apr-15 India’s per capita government expenditure on health in PPP terms is USD44, as against USD809 in Russia, USD474 in Brazil and USD236 in China. Considering that Indians constitute a sixth of humanity, a significant rise in health expenditure is urgently required to ensure universal health coverage. [image: The Hindu]
Read More
03-Apr-15 Between 2002 and 2012 the number of private hospitals in Turkey grew at 14.8% on average. The core growth drivers are favorable government support, internal demand from Turkey’s burgeoning middle class, and external demand as Turkey emerges as a leading healthcare tourism destination. [image: eyeforpharma]
Read More
02-Apr-15 Pfizer Inc said it will cease vaccines sales in China after an import licence for the only vaccine it sold there was not renewed. Drug makers face growing difficulties obtaining approvals in the world’s no. 2 drug market, where pharmaceutical executives say regulators have added more red tape to the process of bringing drugs to market. [image: Fortune]
Read More
02-Apr-15 More private high-end hospitals have come to Shenzhen as its middle-class keeps expanding. The city is also reported to be encouraging private investment in the public health sector. “The city government has... included the hospital into the national health care insurance network to help patients reduce their costs,” said Liu Jiangning, executive president of C-Mer (Shenzhen) Dennis Law Eye Hospital. [image: Shenzhen Standard]
Read MoreGGM is a research and advisory firm helping clients grow profitably in international markets.
We believe the only way to understand a market properly is on the ground. Intelligence from our in-country consultants gives you a competitive advantage in China, Asia, Latin America, the Middle East, Africa and other opportunity areas.
Our clients benefit from accurate data, reliable insights and strategic advice, giving them the confidence to make better business decisions and succeed in their global growth markets.
Successful track record in your sector since 1992
In-country research consultants in over 40 markets
Value for money - quality results at affordable rates
Work led by senior directors with >20 years experience
Proven frameworks for data analysis and strategy
Pragmatic advice based on accurate data and reliable insights
Find out more about our international market intelligence and strategy services
Get in touch to discuss your growth markets research and advisory needs:
Email: info@ggmkts.com